Transcriptomics Brings New Era of Toxicology Prediction Read our Nature article on how transcriptomics with machine learning and AI is transforming toxicology… Learn More
Article: Biomanufacturing Without the Big Bioreactors Learn about J.POD®, our new cGMP manufacturing facility for biologics. Learn More
Webinar: Comprehensive and integrated formulation drug development Our early formulation experts will take you through how having an integrated formulation strategy from… Learn More
Webinar: 5 challenging cases for Evotec’s early formulation experts Ready to solve your bioavailability challenges? Watch our webinar to learn more from our formulation… Learn More
Read our Nature Publication on Eliapixant, a Selective P2X3 Receptor Antagonist Learn about our latest research on a selective P2X3 receptor antagonist for the treatment of… Learn More
Evotec SE reports results for the first half-year 2022 and provides corporate updates August 10, 2022 Learn more
Just – Evotec Biologics and Alpine Immune Sciences expand partnership for commercial process development of ALPN 303 August 9, 2022 Learn more